ArticleFrontiers in medicine2025
Interpretable machine learning for predicting placental abruption in early-onset preeclampsia: model development and evaluation.
Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Integration of angiogenic pathway-related proteomics and clinical features via ensemble learning for precision risk stratification of early-onset preeclampsia.European journal of obstetrics & gynecology and reproductive biology: X · 2026Article
- Gestational-Age Clustering of Recurrent Placental Abruption: A Multicenter Retrospective Descriptive Study.Journal of clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Early-onset preeclampsia (EOPE) represents a particularly severe clinical subtype of preeclampsia (PE) and is frequently complicated by placental abruption, which can result in serious maternal and fetal morbidity or mortality. This study aimed to develop and validate an interpretable machine learning (IML) model for predicting placental abruption in patients with EOPE. Methods: A retrospective cohort of 580 EOPE patients who delivered between January 2021 and June 2025 was analyzed and randomly divided into training (70%) and validation (30%) sets. Dual-step feature selection combining LASSO regression and the Boruta algorithm identified the most relevant predictors. Six supervised algorithms, including decision tree (DT), k-nearest neighbor (KNN), logistic regression, random forest (RF), support vector machine (SVM), and extreme gradient boosting (XGBoost), were developed and compared. Model performance was evaluated using AUC, F1 score, calibration curve, and decision curve analysis (DCA). SHapley Additive exPlanations (SHAP) were employed for model interpretation. Results: Eight optimal predictors were selected: urinary protein, placental growth factor (PlGF), diastolic blood pressure (DBP), age, fibrinogen (FIB), prepregnancy BMI, disease severity, and smoking during pregnancy. The RF model achieved the best performance (training AUC = 0.968; validation AUC = 0.894), along with the highest accuracy and F1 score among all algorithms. Calibration curves showed strong consistency between predicted and observed probabilities, and DCA confirmed greater net clinical benefit across a wide range of threshold probabilities. The confusion matrix demonstrated high sensitivity and specificity, indicating stable classification performance. SHAP analysis revealed that urinary protein, PlGF, FIB, and DBP were the dominant predictors, where elevated urinary protein and DBP and reduced FIB and PlGF significantly increased abruption risk. Conclusion: The SHAP-based RF model demonstrated high predictive accuracy and interpretability, providing a transparent, data-driven framework for individualized risk assessment of placental abruption in EOPE. This interpretable approach may facilitate early risk identification and personalized management in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.